161 related articles for article (PubMed ID: 1387313)
1. Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2.
Cabré F; Moreno JJ; Carabaza A; Ortega E; Mauleón D; Carganico G
Biochem Pharmacol; 1992 Aug; 44(3):519-25. PubMed ID: 1387313
[TBL] [Abstract][Full Text] [Related]
2. 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.
Märki F; Pfeilschifter J; Rink H; Wiesenberg I
FEBS Lett; 1990 May; 264(2):171-5. PubMed ID: 2141575
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins.
Lloret S; Moreno JJ
Biochem Pharmacol; 1992 Oct; 44(7):1437-41. PubMed ID: 1417964
[TBL] [Abstract][Full Text] [Related]
4. Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase.
Moreno JJ
Int Immunopharmacol; 2006 Feb; 6(2):300-3. PubMed ID: 16399636
[TBL] [Abstract][Full Text] [Related]
5. Effect of nonapeptide fragments of uteroglobin and lipocortin I on oedema and mast cell degranulation.
Lloret S; Moreno JJ
Eur J Pharmacol; 1994 Nov; 264(3):379-84. PubMed ID: 7535228
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of vasocortin and nonapeptide fragments of uteroglobin and lipocortin I (antiflammins).
Ialenti A; Doyle PM; Hardy GN; Simpkin DS; Di Rosa M
Agents Actions; 1990 Jan; 29(1-2):48-9. PubMed ID: 2139299
[No Abstract] [Full Text] [Related]
7. Recombinant human type II phospholipase A2 lacks edema producing activity in rat.
Morgan DW; Anderson CM; Meyers KP
Eur J Pharmacol; 1993 Apr; 235(1):45-50. PubMed ID: 8519280
[TBL] [Abstract][Full Text] [Related]
8. Retinoids inhibit phospholipase A2 in human synovial fluid and arachidonic acid release from rat peritoneal macrophages.
Hope WC; Patel BJ; Fiedler-Nagy C; Wittreich BH
Inflammation; 1990 Oct; 14(5):543-59. PubMed ID: 2123476
[TBL] [Abstract][Full Text] [Related]
9. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides.
Marastoni M; Scaranari V; Romualdi P; Donatini A; Ferri S; Tomatis R
Arzneimittelforschung; 1993 Sep; 43(9):997-1000. PubMed ID: 8240467
[TBL] [Abstract][Full Text] [Related]
10. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP
Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides.
Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
Adv Exp Med Biol; 1990; 279():137-60. PubMed ID: 2151414
[No Abstract] [Full Text] [Related]
12. Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: possible mechanism of action.
Facchiano A; Cordella-Miele E; Miele L; Mukherjee AB
Life Sci; 1991; 48(5):453-64. PubMed ID: 1992287
[TBL] [Abstract][Full Text] [Related]
13. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a synthetic nonapeptide from uteroglobin.
Marastoni M; Salvadori S; Balboni G; Scaranari V; Santagada V; Romualdi P; Ferri S; Tomatis R
Arzneimittelforschung; 1991 Mar; 41(3):240-3. PubMed ID: 1867659
[TBL] [Abstract][Full Text] [Related]
14. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I.
Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
Nature; 1988 Oct; 335(6192):726-30. PubMed ID: 2971881
[TBL] [Abstract][Full Text] [Related]
15. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.
Kim K; Jung SY; Lee DK; Jung JK; Park JK; Kim DK; Lee CH
Biochem Pharmacol; 1998 Apr; 55(7):975-85. PubMed ID: 9605421
[TBL] [Abstract][Full Text] [Related]
16. Effects of antiflammins on endotoxin-induced uveitis in rats.
Chan CC; Ni M; Miele L; Cordella-Miele E; Ferrick M; Mukherjee AB; Nussenblatt RB
Arch Ophthalmol; 1991 Feb; 109(2):278-81. PubMed ID: 1993038
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action.
Fawzy AA; Vishwanath BS; Franson RC
Agents Actions; 1988 Dec; 25(3-4):394-400. PubMed ID: 3218613
[TBL] [Abstract][Full Text] [Related]
18. Binding and inhibition studies on lipocortins using phosphatidylcholine vesicles and phospholipase A2 from snake venom, pancreas, and a macrophage-like cell line.
Davidson FF; Lister MD; Dennis EA
J Biol Chem; 1990 Apr; 265(10):5602-9. PubMed ID: 2138608
[TBL] [Abstract][Full Text] [Related]
19. Interaction of synthetic peptides from annexin I and uteroglobin with lipid monolayers and their effect on phospholipase A2 activity.
Newman RH; Freemont PS; Barton GJ; Crumpton MJ
Biochem Soc Trans; 1990 Dec; 18(6):1233-4. PubMed ID: 2150950
[No Abstract] [Full Text] [Related]
20. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2.
Lindahl M; Tagesson C
Inflammation; 1997 Jun; 21(3):347-56. PubMed ID: 9246576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
